| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/24/2004 | CA2290252C Process and intermediates for growth hormone secretagogues |
| 08/24/2004 | CA2285733C Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| 08/19/2004 | WO2004069838A1 Cannabinoid receptor ligands and uses thereof |
| 08/19/2004 | WO2004069837A1 Pyrazolo`1,5-a!`1,3,5!triazine derivatives as cannabinoid receptor ligands |
| 08/19/2004 | WO2004069836A1 Methods for producing quinazoline alkaloids |
| 08/19/2004 | WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069813A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/19/2004 | WO2004069810A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069809A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069257A1 Benzo (1,2,5) thiadiazole als crf-antagonisten |
| 08/19/2004 | WO2004069256A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 08/19/2004 | WO2004069196A2 Novel compounds |
| 08/19/2004 | WO2004056828A3 Novel compounds and uses thereof |
| 08/19/2004 | WO2004029579A3 Fluorescent labeling reagents with multiple donors and acceptors |
| 08/19/2004 | WO2004009036A3 Compounds compositions and methods |
| 08/19/2004 | WO2003051886A8 Pyrazolopyridazine derivatives |
| 08/19/2004 | US20040162428 6-(2,6-difluorophenyl)-triazolopyrimidines as fungicides |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162286 Used for combating phytopathogenic fungi |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | US20040159265 Transition metal or silicon matrix in which particles of an organic pigment are homogeneously embedded or crosslinked; 3-methylidene-2,3-dihydro-indol-2-ones, quinacridone, indigo, diketopyrrolopyrrole, anthraquinone, perylene; thermostable |
| 08/19/2004 | CA2515070A1 Novel compounds |
| 08/19/2004 | CA2514945A1 Methods for producing quinazoline alkaloids |
| 08/19/2004 | CA2514287A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 08/19/2004 | CA2513824A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/19/2004 | CA2513409A1 Pyrazolo`1,5-a!`1,3,5!triazine derivatives as cannabinoid receptor ligands |
| 08/19/2004 | CA2513109A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | CA2512514A1 Benzo (1,2,5) thiadiazole als crf-antagonisten |
| 08/18/2004 | EP1446800A1 Writable high-capacity optical storage media containing metal complexes |
| 08/18/2004 | EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/18/2004 | EP1446401A2 C-5 modified indazolylpyrrolotriazines |
| 08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
| 08/18/2004 | EP1446127A1 Triazepine derivatives as neurotrophic agents |
| 08/18/2004 | EP1349860B1 Syntheses for preparing 1,4-diketopyrrolo[3,4-c]pyrroles |
| 08/18/2004 | EP1341794B1 Fungicidal 6-(trifluoromethyl-phenyl)-triazolopyrimidines |
| 08/18/2004 | EP1286997B1 6-phenylpyrrolopyrimidinedione derivatives |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1521167A 红色有机电致发光材料 Red organic electroluminescent material |
| 08/18/2004 | CN1162431C Process for preparation of pyrimido [5,4-g] pteridine derivatives |
| 08/18/2004 | CN1162405C Substd. benzoyl ketones, methods for producing them and their use as herbicides |
| 08/18/2004 | CN1162403C Substituted amino benzonitrile |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777551 Process for the preparation of sulphonamide-substituted imidazotriazinones |
| 08/17/2004 | US6777419 Pyrazolo [4,3-d]pyrimidines |
| 08/17/2004 | US6777407 7bh-cyclopenta(b)(1,4)diazepino(6, 7, 1-hi)indole or a salt, useful for treatment of schizophrenia, obsessive compulsive disorder, depression, anxiety, panic disorder, obesity or epilepsy |
| 08/17/2004 | US6777402 Acidic alcoholysis of biological raw material giving crystalline alkyl pheophorbide; conversion of alkyl pheophorbide into an acidic porphyrin; reaction of the acidic porphyrin with a hydrophylic organic amine |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/12/2004 | WO2004067533A1 Conducting polymers with porphyrin cross-linkers |
| 08/12/2004 | WO2004052286A3 Tyrosine kinase inhibitors |
| 08/12/2004 | WO2004046151A3 Porphyrin derivatives |
| 08/12/2004 | WO2004046120A3 Diaminotriazoles useful as inhibitors of protein kinases |
| 08/12/2004 | WO2004030635A3 Vasculostatic agents and methods of use thereof |
| 08/12/2004 | WO2004007498A9 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 08/12/2004 | US20040158066 Compounds for controlling Helicobacteria |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157906 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157891 Inhibitor of cox |
| 08/12/2004 | US20040157880 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 08/12/2004 | US20040157878 Alzheimer 's disease; parkinson's disease; schizophrenia; antidepressants; anxiolytic agents; brain disorders; psychological disorders |
| 08/12/2004 | US20040157873 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
| 08/12/2004 | US20040157863 Triazolopyrimidines |
| 08/12/2004 | US20040157853 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 08/12/2004 | US20040157852 cancer, diabetes, hepatic cirrhosis, atherosclerosis, angiogenesis and renal disease |
| 08/12/2004 | US20040157851 utility over a wide range of therapeutic applications, and may be used to treat a variety of disorders or illnesses, including stress-related disorders; depression, anxiety, stroke |
| 08/12/2004 | US20040157846 Process for preparing pyrrolotriazine kinase inhibitors |
| 08/12/2004 | US20040157839 substituted pyrazolo[1,5-a][1,3,5]triazine compounds; in particular CB1 receptor antagonists |
| 08/12/2004 | US20040157838 pyrazolo[1,5-a]pyrimidine compounds; in particular CB1 receptor antagonists; antiobesity; antidepressant |
| 08/12/2004 | US20040157820 can stably transport oxygen; blood substitute for patients of a rare blood type, patients refusing blood transfusion for religious reasons and animal care |
| 08/12/2004 | US20040157804 inhibition of HIV integrase |
| 08/12/2004 | US20040157264 Piperazine melanocortin-specific compounds |
| 08/12/2004 | US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 08/12/2004 | US20040156790 Delivery of drug esters through an inhalation route |
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | US20040156787 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic theraphy and in vivo diagnostic |
| 08/12/2004 | US20040156783 Complexes of cyanine, indocyanine, phthalocyanine, rhodamine, oxazine, thiazine, phenoselenazines, fluoresceins, porphyrin, squaraine, corrins, croconium, azo, methine and/or indolenium dye linked with receptor binding molecules; tumors |
| 08/12/2004 | DE10303696A1 Entfärbung und Farbstabilisierung von TEDA-Lösung Decolorization and color stabilization of TEDA solution |
| 08/11/2004 | EP1444236A1 Separation of regioisomers of metal phthalocyanines |
| 08/11/2004 | EP1444235A1 Reverse-turn mimetics and method relating thereto |
| 08/11/2004 | EP1444234A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 08/11/2004 | EP1444228A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 08/11/2004 | EP1444209A2 Mitotic kinesin inhibitors |
| 08/11/2004 | EP1444009A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
| 08/11/2004 | EP1443822A1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones |
| 08/11/2004 | EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/11/2004 | EP0760657B9 Novel potent inducers of terminal differentiation and methods of use thereof |
| 08/11/2004 | CN1520414A Novel compound, its prepn. and application |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1161343C Cholopyrimidine intermediate |
| 08/10/2004 | US6774237 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents |
| 08/10/2004 | US6774236 Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives |